Research ArticleGastrointestinal, Hepatic, Pulmonary, and Renal
Open Access
The GPR40 Full Agonist SCO-267 Improves Liver Parameters in a Mouse Model of Nonalcoholic Fatty Liver Disease without Affecting Glucose or Body Weight
Mitsugi Ookawara, Keisuke Matsuda, Masanori Watanabe and Yusuke Moritoh
Journal of Pharmacology and Experimental Therapeutics October 2020, 375 (1) 21-27; DOI: https://doi.org/10.1124/jpet.120.000046